Meldungen zum Thema Medizin, Gesundheit

FIBO

FIBO 2026: AI Drives the Longevity & Health Boom

Cologne (ots) - FIBO 2026, the world’s leading trade show for fitness, wellness, and health, marks a strategic shift in the industry toward data-driven health and longevity models. Where traditional strength training once dominated, digital applications, connected systems, and AI-powered analytics are now shaping market development. FIBO is positioning itself as an international platform and catalyst for a new ...

STADA Arzneimittel AG

Press Release: Enzymatica and STADA sign partnership agreement for Germany and Austria

Press Release Enzymatica and STADA sign partnership agreement for Germany and Austria - New partnership agreement covers thelaunch and distribution of Enzymatica’s ColdZyme® oral-spray technology in Germany and Austria - Alliance combines Enzymatica’s clinically documented medical device with ...

FUTRUE GmbH

FUTRUE Neurosciences Reaches Major Milestone

PNO Innovation GmbH

canSERV: Impact and Future Perspectives Event

LAUDA DR. R. WOBSER GMBH & CO. KG

LAUDA Honors Elmar Mohr for 40 Years of Service

DHL Group

5

PR: DHL expands its North America logistics infrastructure amid growing global demand for data center logistics services / PM: DHL expands its North America logistics infrastructure amid growing global demand for data center logistics services

Fraunhofer IOF

3

New Scattered Light Method enables faster Analysis of Bacteria and Antibiotic Resistance

Aid by Trade Foundation

6

World Water Day 22.03.2026: Hamburg-based Aid by Trade Foundation Improves Drinking Water Supply and Equal Opportunities for Girls in Africa

GEA Group Aktiengesellschaft

2

IFAT, Munich: Invitation to the Press Conference “Smart Automation for Lower Costs”

STADA Arzneimittel AG

2

Press Release: STADA’s Strong Growth Journey Continues in 2025

Helmholtz Munich

100,000 Participants Screened for Early-Stage Type 1 Diabetes in the EDENT1FI Project

EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an important milestone toward its goal, having screened 100,000 of the more than 200,000 children and adolescents ...

Grünenthal Group

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm

Aachen, Germany & Yeoju, South Korea (ots) - Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will ...

Grünenthal Group

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands

Aachen, Germany (ots) - - Grünenthal acquired Kyowa Kirin International's 49% stake in 'Grünenthal Meds', a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. - Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 ...

Fraunhofer IOF

3

Quantum communication in real-world operation

Ottobock SE & Co. KGaA

Ottobock invests in future technology from Blue Arbor Technologies, Inc.

Medi-Globe GmbH

3

Medi-Globe Launches mAI  Companion® - the World’s First Real‑Time  AI  Assistant for Pancreatic  EUS, Co‑Developed  with  IHU  Strasbourg  / Now  MDR  CE‑Marked  and  Available  for  Clinical  Use  in  Europe

Grünenthal Group

Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect

Aachen, Germany & Victoria, Australia (ots) - Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a ...

Europäischer Rechnungshof - European Court of Auditors

EU’s ambitious plan to combat cancer suffers from uncertainty

DHL Group

5

PM: DHL Group stärkt Logistik für das weltweite Gesundheitswesen durch Ausbau des Kühlkettennetzwerks in der Luftfracht / PR: DHL Group Expands Airfreight Cold Chain Network to Advance Global Health Logistics

Grünenthal Group

Grünenthal’s proprietary NaV 1.8 inhibitor enters clinical development

Aachen, Germany (ots) - Grünenthal announced today that the first healthy volunteers have been enrolled in a Phase I trial of its voltage-gated sodium channel (NaV) 1.8 inhibitor. The orally administered investigational medicine aims to provide a non-opioid therapy option across a range of acute and chronic pain conditions. Full results of the trial are expected in ...

Ottobock SE & Co. KGaA

Record results for Ottobock: Double-digit growth, strong profit growth, positive outlook

STADA Arzneimittel AG

Press Release: STADA invests more than €85m in Saudi Arabia manufacturing hub

STADA Arzneimittel AG

Press Release: STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi

STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi - European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA ...

Europäischer Rechnungshof - European Court of Auditors

Koronakriisin jälkeinen EU:n 650 miljardin euron elpymisrahasto: varoja suojataan petoksilta hajanaisesti